Idifarma, a Spanish contract development and manufacturing organization (CDMO) specializing in niche and highly potent products, has appointed Alfredo Gómez as its head of site.
 
In his new role, Gómez will be responsible for ensuring the company continues to deliver tailored development, manufacturing, and regulatory solutions to pharma companies to speed up their path to market.
 
With over 20 years’ experience in strategic operations within the pharmaceutical industry, Gómez has joined the company from his most recent position at Praxis Pharmaceutical, where he was site director for almost a decade.
 
Idifarma believes his experience and expertise will support the planned expansion of the business across European and U.S. markets and in product areas with growing demand like oncology.
 
Commenting on his new role, Gómez said, “Idifarma is well respected in the industry with an impressive track record of operating with niche, innovative and highly potent oral drugs, and using flexibility and specialization to meet customer demands. I’m looking forward to contributing to its continued success and future growth.”